España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Amneal Pharmaceuticals
AMRX
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$7.26
0.03
0.35%
Last update: 10:19 AM
15 minutes delayed
Get Report
Comment
Amneal Pharmaceuticals (AMRX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Amneal Pharmaceuticals (NASDAQ:AMRX) Stock
Amneal Pharmaceuticals Stock (NASDAQ: AMRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 09, 2024
Amneal Pharmaceuticals Launches Focinvez, Rea...
Benzinga Newsdesk
Monday, July 01, 2024
Kashiv BioSciences Enters Into Exclusive Lice...
Benzinga Newsdesk
Tuesday, June 11, 2024
Reported Monday June 10, 2024 "Amneal, U.S. F...
Benzinga Newsdesk
Wednesday, June 05, 2024
Amneal Expands Broad Injectables Portfolio Wi...
Benzinga Newsdesk
Wednesday, May 22, 2024
Amneal Has Begun Supplying OTC Naloxone Hydro...
Benzinga Newsdesk
Monday, May 06, 2024
Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts
Benzinga Insights
Goldman Sachs Maintains Buy on Amneal Pharmac...
Benzinga Newsdesk
Truist Securities Reiterates Buy on Amneal Ph...
Benzinga Newsdesk
Friday, May 03, 2024
Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement
Vandana Singh
CORRECTION: Amneal Reaffirms 2024 Revenue Gui...
Benzinga Newsdesk
Amneal Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Amneal Pharmaceuticals Q1 2024 Adj EPS $0.14 ...
Benzinga Newsdesk
Wednesday, April 24, 2024
Amneal Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Amneal Announces FDA Approval Of Over-The-Cou...
Benzinga Newsdesk
Tuesday, April 16, 2024
Amneal Launches PEMRYDI RTU, The First Ready-...
Benzinga Newsdesk
Friday, April 05, 2024
Bausch Health Announces Patent Lawsuit Agains...
Benzinga Newsdesk
Monday, March 25, 2024
Amneal Receives FDA Approval For Ciprofloxaci...
Benzinga Newsdesk
Friday, March 22, 2024
FTC Files Amicus Brief in Asthma Inhaler Pate...
Benzinga Newsdesk
Thursday, March 21, 2024
Piper Sandler Maintains Overweight on Amneal ...
Benzinga Newsdesk
Monday, March 04, 2024
Goldman Sachs Maintains Buy on Amneal Pharmac...
Benzinga Newsdesk
Friday, March 01, 2024
Why Is Generic Drug-Focused Amneal Pharmaceuticals Stock Trading Lower Friday?
Vandana Singh
Amneal Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Earnings Scheduled For March 1, 2024
Benzinga Insights
Amneal Pharmaceuticals: Q4 Earnings Insights
Benzinga Insights
Amneal Expects Fiscal Year 2024 Adjusted EBIT...
Benzinga Newsdesk
Amneal Forecasts Fiscal Year 2024 Revenues Of...
Benzinga Newsdesk
Amneal Pharmaceuticals Q4 Adjusted EPS $0.14 ...
Benzinga Newsdesk
Thursday, February 29, 2024
Earnings Outlook For Amneal Pharmaceuticals
Benzinga Insights
Tuesday, February 27, 2024
Amneal Enters Into Exclusive European Licensi...
Benzinga Newsdesk
Thursday, February 08, 2024
Amneal Reports Complete Response Resubmission...
Benzinga Newsdesk
Monday, January 29, 2024
Barclays Maintains Overweight on Amneal Pharm...
Benzinga Newsdesk
Thursday, January 25, 2024
Knight Therapeutics Enters Exclusive License ...
Benzinga Newsdesk
Wednesday, January 10, 2024
Amneal Launches Complex Generic Fluorometholo...
Benzinga Newsdesk
Friday, January 05, 2024
Akram Mahesh Reports 9.9% Passive Stake In Am...
Benzinga Newsdesk
Friday, December 15, 2023
Amneal Pharmaceuticals Announced That It Will...
Benzinga Newsdesk
Thursday, December 07, 2023
Amneal Pharmaceuticals Announced Licensing Ag...
Benzinga Newsdesk
Wednesday, November 08, 2023
Truist Securities Maintains Buy on Amneal Pha...
Benzinga Newsdesk
Truist Securities Maintains Buy on Amneal Pha...
Benzinga Newsdesk
Tuesday, November 07, 2023
Earnings Scheduled For November 7, 2023
Benzinga Insights
Amneal Affirms 2023 Net Revenue Outlook Of $2...
Benzinga Newsdesk
Amneal Pharmaceuticals Q3 Adj EPS $0.19 Beats...
Benzinga Newsdesk
Tuesday, October 24, 2023
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Amneal Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
General Electric, Verizon, Cleveland-Cliffs And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
Monday, October 23, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Amneal Pharmaceuticals Sees Prelim. Q3 Net Re...
Benzinga Newsdesk
Thursday, October 12, 2023
Amneal Pharmaceuticals Announced The Addition...
Benzinga Newsdesk
Friday, October 06, 2023
NuScale Power, Stagwell And Other Big Stocks Moving Higher On Friday
Lisa Levin
Wednesday, September 06, 2023
Amneal Receives U.S. FDA Approval For Calcium Gluconate Injection; Key Injectable Currently On The U.S. FDA Shortage List; Received Competitive Generic Therapy Approval Designation
Happy Mohamed
Analyst Ratings for Amneal Pharmaceuticals
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch